PPA
GRTS

Parametric Portfolio Associates’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Parametric Portfolio Associates’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$205K Sell
49,741
-13,858
-22% -$73.4K ﹤0.01% 3435
2021
Q4 		$818K Buy
63,599
+13,779
+28% +$153K ﹤0.01% 2864
2021
Q3 		$538K Sell
49,820
-3,019
-6% -$27.5K ﹤0.01% 3074
2021
Q2 		$482K Buy
52,839
+882
+2% +$8.16K ﹤0.01% 3102
2021
Q1 		$490K Sell
51,957
-251
-0.5% -$3.46K ﹤0.01% 3506
2020
Q4 		$206K Buy
52,208
+7,158
+16% +$21.6K ﹤0.01% 3761
2020
Q3 		$119K Buy
+45,050
New +$167K ﹤0.01% 3762

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Parametric Portfolio Associates's GRTS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Gritstone bio, Inc. Common Stock (GRTS) stake by 22% in Q1 2022, selling an estimated $73.4K and leaving 49,741 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3435.

Parametric Portfolio Associates first reported a position in GRTS in Q3 2020 and has held it in 7 quarters since. The position peaked at $818K in Q4 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • Parametric Portfolio Associates held 49,741 shares of Gritstone bio, Inc. Common Stock worth $205K as of Q1 2022.
  • Parametric Portfolio Associates sold 13,858 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $73.4K.
  • Gritstone bio, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3435 holding.
  • Parametric Portfolio Associates first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's Gritstone bio, Inc. Common Stock position peaked at $818K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.